Efficacy of automated insulin delivery in pregnant women with type 1 diabetes: a meta-analysis and trial sequential analysis of randomized controlled trials
- PMID: 38700546
- DOI: 10.1007/s00592-024-02284-3
Efficacy of automated insulin delivery in pregnant women with type 1 diabetes: a meta-analysis and trial sequential analysis of randomized controlled trials
Abstract
Background: Automated insulin delivery (AID) devices have shown to be a promising treatment to improve glycemic control in patients with type 1 diabetes mellitus (T1DM). However, its efficacy in pregnant women with T1DM remains uncertain.
Methods: PubMed, Scopus, Cochrane Central and ClinicalTrials.gov were systematically searched for randomized controlled trials (RCTs) comparing AID to standard care (SC), defined as use of sensor-augmented pump and multiple daily insulin injections. Outcomes included time in range (TIR), nocturnal TIR, time in hypoglycemic and hyperglycemic ranges, among others. Sensitivity and trial sequential analyses (TSA) were performed.
Prospero id: CRD42023474398.
Results: We included five RCTs with a total of 236 pregnant women, of whom 117 (50.6%) received AID. There was a significant increase in nocturnal TIR (mean difference [MD] 12.69%; 95% CI 8.74-16.64; p < 0.01; I2 = 0%) and a decrease in glucose variability (standard deviation of glucose; MD -2.91; 95% CI -5.13 to -0.69; p = 0.01; I2 = 0%). No significant differences were observed for TIR, HBGI, LGBI, mean glucose and time spent in hyperglycemia and hypoglycemia. Regarding TSA, the statistical significance obtained in nocturnal TIR was conclusive and with minimal risk of a type I error.
Conclusion: Our findings suggest that AID systems can significantly improve nocturnal glycemic control and potentially reduce glycemic variability in pregnant women with T1DM, with no effect in the risk of hypoglycemia and hyperglycemia compared with current insulin treatments.
Keywords: Automated insulin delivery; Hybrid closed-loop system; Pregnancy; Type 1 diabetes.
© 2024. Springer-Verlag Italia S.r.l., part of Springer Nature.
Similar articles
-
Automated insulin delivery in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis.Acta Diabetol. 2025 Apr;62(4):441-452. doi: 10.1007/s00592-025-02446-x. Epub 2025 Jan 10. Acta Diabetol. 2025. PMID: 39792171 Free PMC article.
-
Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial.Diabetes Care. 2018 Jul;41(7):1391-1399. doi: 10.2337/dc17-2534. Epub 2018 Mar 13. Diabetes Care. 2018. PMID: 29535135 Clinical Trial.
-
Efficacy and Safety of Automated Insulin Delivery Systems in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.Diabetes Metab J. 2025 Mar;49(2):235-251. doi: 10.4093/dmj.2024.0130. Epub 2024 Nov 13. Diabetes Metab J. 2025. PMID: 39533812 Free PMC article.
-
Real-world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta-analysis.Diabetes Obes Metab. 2024 Sep;26(9):3753-3763. doi: 10.1111/dom.15718. Epub 2024 Jun 18. Diabetes Obes Metab. 2024. PMID: 38888056
-
Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes.N Engl J Med. 2016 Aug 18;375(7):644-54. doi: 10.1056/NEJMoa1602494. N Engl J Med. 2016. PMID: 27532830 Clinical Trial.
Cited by
-
Automated insulin delivery in pregnant women with type 1 diabetes: a systematic review and meta-analysis.Acta Diabetol. 2025 Aug;62(8):1325-1335. doi: 10.1007/s00592-025-02454-x. Epub 2025 Jan 17. Acta Diabetol. 2025. PMID: 39821308
-
Human-machine co-adaptation to automated insulin delivery: a randomised clinical trial using digital twin technology.NPJ Digit Med. 2025 May 6;8(1):253. doi: 10.1038/s41746-025-01679-y. NPJ Digit Med. 2025. PMID: 40329052 Free PMC article.
-
Closed-loop systems: recent advancements and lived experiences.Expert Rev Med Devices. 2024 Oct;21(10):927-941. doi: 10.1080/17434440.2024.2406901. Epub 2024 Oct 10. Expert Rev Med Devices. 2024. PMID: 39390689 Free PMC article. Review.
-
Automated insulin delivery in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis.Acta Diabetol. 2025 Apr;62(4):441-452. doi: 10.1007/s00592-025-02446-x. Epub 2025 Jan 10. Acta Diabetol. 2025. PMID: 39792171 Free PMC article.
References
-
- Gregory GA, Robinson TIG, Linklater SE et al (2022) Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes Endocrinol 10(10):741–760. https://doi.org/10.1016/S2213-8587(22)00218-2 - DOI - PubMed
-
- Benhalima K, Beunen K, Siegelaar SE et al (2023) Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets. Lancet Diabetes Endocrinol 11(7):490–508. https://doi.org/10.1016/S2213-8587(23)00116-X - DOI - PubMed
-
- Alexopoulos AS, Blair R, Peters AL (2019) Management of preexisting diabetes in pregnancy: a review. JAMA 321(18):1811–1819. https://doi.org/10.1001/JAMA.2019.4981 - DOI - PubMed - PMC
-
- Pettus JH, Zhou FL, Shepherd L et al (2019) Incidences of severe hypoglycemia and diabetic ketoacidosis and prevalence of microvascular complications stratified by age and glycemic control in U.S. adult patients with type 1 diabetes: a real-world study. Diabetes Care. 42(12):2220–2227. https://doi.org/10.2337/DC19-0830 - DOI - PubMed
-
- Foster NC, Beck RW, Miller KM et al (2019) State of type 1 diabetes management and outcomes from the T1D exchange in 2016–2018. Diabetes Technol Ther 21(2):66–72. https://doi.org/10.1089/DIA.2018.0384 . https://home.liebertpub.com/dia
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials